Chidamide

CAS No.	743420-02-2	Cat. No.	BCP13386
Name	Chidamide
Synonyms	CS055; CS-055; CS 055; HBI-8000; HBI 8000; HBI8000; Tucidinostat;
Formula	C22H19FN4O2	M. Wt	390.42

Description	Chidamide, also known as Tucidinostat ,CS055 and HBI-8000, is an orally bioavailable benzamide type inhibitor of histone deacetylase (HDAC) isoenzymes 1, 2, 3 and 10, with potential antineoplastic activity. Chidamide selectively binds to and inhibits HDAC leading to an increase of acetylation levels of histone protein H3. This agent also inhibits the expression of signaling kinases in the PI3K/Akt and MAPK/Ras signaling pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis. This may inhibit tumor cell proliferation in susceptible tumor cells. HDACs, a class of enzymes that deacetylate chromatin histone proteins, are upregulated in many tumor types and play key roles in gene expression. Compared to some other benzamide type HDAC inhibitors, chidamide is more stable, more resistant to degradation and has a longer half-life
Pathways	Cell Cycle/DNA Damage Epigenetics
Targets	HDAC

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.